Pier 70 Ventures

Pier 70 Ventures is a venture capital firm based in Seattle, launched in 2020 by former Boeing executives with a focus on healthcare and med-tech innovation. The firm operates with a mission to fund impact-driven companies, especially those leveraging AI, data, and cloud technologies to reshape healthcare. Pier 70 is particularly known for supporting diverse leadership teams and sees diversity as a key driver for financial returns. Their areas of interest include digital health, diagnostics, and med-tech. The founding team, which includes industry veterans like R. Miller Adams, Shaun Hawkins, and Bob Balk, brings deep expertise from both the corporate and investment worlds. For example, Adams and Balk developed Boeing’s venture capital arm, growing it into a $250 million fund-of-funds. At Pier 70, they aim to replicate this success by connecting startups with a global network of healthcare leaders, corporate investors, and biopharma companies. Pier 70's initial fund, the INpact Fund, focuses on early-stage to Series B investments, with check sizes ranging from $250,000 to $2 million. The firm is committed to fostering innovation and reducing economic inequality by backing underrepresented entrepreneurs. They’ve already made notable investments in startups like DocSpera, a surgical coordination platform, and Acclinate, a company focused on increasing diversity in clinical trials. Pier 70 aims to fund up to 22 companies with its first fund, contributing not just capital but strategic guidance to help startups scale and thrive.